2254 related articles for article (PubMed ID: 19330875)
1. Diagnosis, management, and treatment of hepatitis C: an update.
Ghany MG; Strader DB; Thomas DL; Seeff LB;
Hepatology; 2009 Apr; 49(4):1335-74. PubMed ID: 19330875
[No Abstract] [Full Text] [Related]
2. SASLT practice guidelines: management of hepatitis C virus infection.
Alghamdi AS; Sanai FM; Ismail M; Alghamdi H; Alswat K; Alqutub A; Altraif I; Shah H; Alfaleh FZ;
Saudi J Gastroenterol; 2012 Sep; 18 Suppl(Suppl 1):S1-32. PubMed ID: 23006491
[No Abstract] [Full Text] [Related]
3. Hepatitis C: Enhancing treatment for hepatitis C among drug users.
Grebely J; Dore GJ
Nat Rev Gastroenterol Hepatol; 2011 Jan; 8(1):11-3. PubMed ID: 21119610
[No Abstract] [Full Text] [Related]
4. Clinical decisions. Management of incidental hepatitis C virus infection--polling results.
Wilck MB; Hamel MB; Baden LR
N Engl J Med; 2009 Jun; 360(23):e30. PubMed ID: 19494211
[No Abstract] [Full Text] [Related]
5. [Hepatitis C].
Pache I; Gonvers JJ
Rev Med Suisse Romande; 2002 Oct; 122(10):507-12. PubMed ID: 12494784
[No Abstract] [Full Text] [Related]
6. Consensus interferon used to treat prior partial-responders to pegylated interferon plus ribavirin.
Moore CM; George M; Van Thiel DH
Dig Dis Sci; 2011 Oct; 56(10):3032-7. PubMed ID: 21879283
[TBL] [Abstract][Full Text] [Related]
7. Effect of Eradication of HCV on Hepatic Venous Pressure Gradient in HIV-Infected Patients With Compensated HCV-Related Cirrhosis.
Sánchez-Conde M; Pérez-Latorre L; Rincón D; Miralles P; Catalina MV; López JC; Bañares R; Berenguer J
J Acquir Immune Defic Syndr; 2015 Aug; 69(4):e142-4. PubMed ID: 25861016
[No Abstract] [Full Text] [Related]
8. Response predictors and clinical benefits of hepatitis C retreatment with pegylated interferon and ribavirin in HIV/HCV coinfection.
Peribañez-Gonzalez M; da Silva MH; Vilar FC; Seixas-Santos Nastri AC; Ferreira PA; Focaccia R; Mendes Correa MC
Ann Hepatol; 2013; 12(2):228-35. PubMed ID: 23396734
[TBL] [Abstract][Full Text] [Related]
9. Treatment of recurrent hepatitis C virus infection after liver transplantation with interferon and ribavirin.
Götz G; Schön MR; Haefker A; Neuhaus R; Berg T; Hopf U; Neuhaus P
Transplant Proc; 1998 Aug; 30(5):2104-6. PubMed ID: 9723407
[No Abstract] [Full Text] [Related]
10. HBV plus HCV, HCV plus HIV, HBV plus HIV.
Park JS; Saraf N; Dieterich DT
Curr Gastroenterol Rep; 2006 Feb; 8(1):67-74. PubMed ID: 16510037
[TBL] [Abstract][Full Text] [Related]
11. [Antiviral treatment in liver cirrhosis due to hepatitis C virus].
Martínez-Bauer E; Forns X
Gastroenterol Hepatol; 2003 May; 26(5):303-6. PubMed ID: 12732104
[No Abstract] [Full Text] [Related]
12. The effect and safety of the treatment of recurrent hepatitis C infection after orthotopic liver transplantation with pegylated interferon α2b and ribavirin.
Perrakis A; Yedibela S; Schuhmann S; Croner R; Schellerer V; Demir R; Hohenberger W; Müller V
Transplant Proc; 2011 Dec; 43(10):3824-8. PubMed ID: 22172854
[TBL] [Abstract][Full Text] [Related]
13. [Peg-IFNa-2a/RBV antiviral efficacy in cirrhotic hepatitis C patients after splenectomy or partial splenic embolization].
Xie YM; Li B; Ma L; Pan L; Wei X; Peng XJ; Hao CQ; Zhang Y; Bai XF; Kang WZ; Jia ZS
Zhonghua Gan Zang Bing Za Zhi; 2012 Feb; 20(2):112-5. PubMed ID: 22464782
[TBL] [Abstract][Full Text] [Related]
14. Chronic hepatitis C: treatment of pegylated interferon/ribavirin nonresponders.
Shiffman ML
Curr Gastroenterol Rep; 2006 Feb; 8(1):46-52. PubMed ID: 16510034
[TBL] [Abstract][Full Text] [Related]
15. Clinical decisions. Management of incidental hepatitis C virus infection.
Afdhal NH; Lok AS; Di Bisceglie AM
N Engl J Med; 2009 Apr; 360(18):1902-6. PubMed ID: 19403909
[No Abstract] [Full Text] [Related]
16. Consensus interferon: tailored therapy and the impact of adherence.
Gonzalez SA
Dig Dis Sci; 2011 Mar; 56(3):631-4. PubMed ID: 21259073
[No Abstract] [Full Text] [Related]
17. [Drug therapy of hepatitis B and C].
Färkkilä M
Duodecim; 2003; 119(6):519-29. PubMed ID: 12708339
[No Abstract] [Full Text] [Related]
18. Regression of esophageal varices and splenomegaly in two patients with hepatitis-C-related liver cirrhosis after interferon and ribavirin combination therapy.
Lee SJ; Cho YK; Na SY; Choi EK; Boo SJ; Jeong SU; Song HJ; Kim HU; Kim BS; Song BC
Clin Mol Hepatol; 2016 Sep; 22(3):390-395. PubMed ID: 27572075
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C: the 'silent stalker'.
Harkness GA
Am J Nurs; 2003 Sep; 103(9):24-5. PubMed ID: 14506802
[No Abstract] [Full Text] [Related]
20. [Management of chronic hepatitis C which failed to respond to previous treatment].
Bronowicki JP; Nani A; Barraud H
Gastroenterol Clin Biol; 2009 Apr; 33(4):345-52. PubMed ID: 19349132
[No Abstract] [Full Text] [Related]
[Next] [New Search]
